William Blair Comments on Encompass Health Co.’s Q1 2024 Earnings (NYSE:EHC)

Encompass Health Co. (NYSE:EHCFree Report) – Equities researchers at William Blair issued their Q1 2024 earnings per share (EPS) estimates for shares of Encompass Health in a note issued to investors on Wednesday, February 7th. William Blair analyst J. Haase expects that the company will earn $0.91 per share for the quarter. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $3.91 per share. William Blair also issued estimates for Encompass Health’s Q2 2024 earnings at $0.97 EPS, Q3 2024 earnings at $1.06 EPS, Q4 2024 earnings at $1.03 EPS, FY2024 earnings at $3.91 EPS and Q4 2025 earnings at $1.19 EPS.

A number of other equities analysts have also issued reports on EHC. Royal Bank of Canada reissued an “outperform” rating and issued a $83.00 price objective on shares of Encompass Health in a report on Friday. Stephens reissued an “overweight” rating and set a $85.00 price objective on shares of Encompass Health in a research note on Tuesday, January 16th. Truist Financial raised their price objective on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Mizuho increased their target price on Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a report on Friday. One analyst has rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health currently has an average rating of “Buy” and a consensus target price of $79.89.

View Our Latest Research Report on EHC

Encompass Health Stock Up 0.8 %

Shares of Encompass Health stock opened at $73.52 on Monday. Encompass Health has a twelve month low of $51.15 and a twelve month high of $76.84. The stock has a market capitalization of $7.37 billion, a price-to-earnings ratio of 21.19, a PEG ratio of 1.31 and a beta of 0.92. The business’s 50 day simple moving average is $68.83 and its 200-day simple moving average is $67.57. The company has a current ratio of 1.28, a quick ratio of 1.27 and a debt-to-equity ratio of 1.19.

Institutional Investors Weigh In On Encompass Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. US Bancorp DE lifted its stake in Encompass Health by 66.4% during the first quarter. US Bancorp DE now owns 9,336 shares of the company’s stock worth $664,000 after purchasing an additional 3,725 shares during the period. Cambridge Investment Research Advisors Inc. acquired a new position in shares of Encompass Health in the 1st quarter worth approximately $318,000. PNC Financial Services Group Inc. boosted its holdings in shares of Encompass Health by 10.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 8,750 shares of the company’s stock worth $622,000 after acquiring an additional 834 shares in the last quarter. Bank of Montreal Can boosted its holdings in shares of Encompass Health by 1.5% in the 1st quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock worth $806,000 after acquiring an additional 173 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in shares of Encompass Health by 10.5% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 36,463 shares of the company’s stock worth $2,593,000 after acquiring an additional 3,477 shares in the last quarter. 92.66% of the stock is owned by institutional investors and hedge funds.

About Encompass Health

(Get Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Featured Articles

Earnings History and Estimates for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.